MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UP-28-0022153
Oziel Pharmaceuticals Private Limited - pharma in Noida, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹10.29 Cr
▲ 14% YoY
Net profit · FY 2025
₹12.87 Lakh
Net margin 1.3%
EBITDA · FY 2025
₹47.44 Lakh
EBITDA margin 4.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹1.3 Cr
Secured borrowings
Company age
11 yrs
Est. 2015
Employees · EPFO
66
Provident fund records
About Oziel Pharmaceuticals Private Limited
Data last updated:
Oziel Pharmaceuticals Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U85191UP2015PTC071100. Its GSTIN is 09AACCO1538J1ZC (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Kamal Kishore Singh and Manish Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Noida, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.29 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹12.87 Lakh (net margin 1.3%) and EBITDA of ₹47.44 Lakh (EBITDA margin 4.6%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 13% over five years.
The company has about 66 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Oziel Pharmaceuticals. As per MCA filings, the company has open charges of ₹1.3 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.
Oziel Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0022153). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website oziel.co.in.
Company details
CIN U85191UP2015PTC071100
Registration Number 071100
Incorporation Date 03 June 2015
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UP-28-0022153
Recognitions & Rankings of Oziel Pharmaceuticals
Contact details
Oziel Pharmaceuticals Private Limited's registered office is in Noida, Uttar Pradesh. Its website is oziel.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No – A – 326 Sector – 69, Transport Nagar, Noida, Uttar Pradesh, India – 201301
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Oziel Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Oziel Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Oziel Pharmaceuticals operates one associated brand: Oziel Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical company specializing in dermatology and cosmetic products, with operations in clinical solutions and online distribution in India. | oziel.co.in |
Business activity
The main business activity of Oziel Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Oziel Pharmaceuticals Private Limited, buy the company report.
Financials of Oziel Pharmaceuticals Private Limited
FY 2025 filings availableOziel Pharmaceuticals Private Limited reported revenue of ₹10.29 Cr (up 14% YoY) for FY 2025.
Revenue · FY 2025
₹10.29 Cr ▲ 14%
Net profit · FY 2025
₹12.87 Lakh margin 1.3%
EBITDA · FY 2025
₹47.44 Lakh margin 4.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 14%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 32%
5 years · compounded
▲ 18%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 14% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹47.44 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.87 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.6% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oziel Pharmaceuticals Private Limited, buy the company report.
Board of directors of Oziel Pharmaceuticals Private Limited
Oziel Pharmaceuticals has 5 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kamal Kishore Singh | Director | 03 Jun 2015 | 11 Years 4 Months | Current |
| Manish Mishra | Director | 03 Jun 2015 | 11 Years 4 Months | Current |
| Mayank Chaubey | Director | 03 Jun 2015 | 11 Years 4 Months | Current |
| Vamsi Vijjapu | Director | 03 Jun 2015 | 11 Years 4 Months | Current |
| Ritesh Kumar Gupta | Director | 03 Jun 2015 | 11 Years 4 Months | Current |
Peer comparison
Oziel Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Banson Pharmaceuticals Private Limited | ₹10.3 Cr (FY 2024) | 92.0% | Punjab, India | |||
| Oziel Pharmaceuticals Private Limitedthis company | ₹10.29 Cr (FY 2025) | ₹12.87 Lakh | 1.3% | 14.0% | 66 | Noida, Uttar Pradesh, India |
| Sabkind Pharmaceuticals India Private Limited | ₹10.2 Cr (FY 2025) | 255.0% | Mysore, Karnataka, India | |||
| Maharshi Badri Pharmaceuticals Private Limited | ₹10.19 Cr (FY 2024) | -12.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Oziel Pharmaceuticals Private Limited, buy the company report.
Auditor
Oziel Pharmaceuticals Private Limited is audited by KAPIL VERMA & COMPANY for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KAPIL VERMA & COMPANY | FY 2021 | 016914C |
Shareholding
The shareholding of Oziel Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Oziel Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.3 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Dec 2023 | 100839162 | Hdfc Bank Limited | ₹14 Lakh | Open | |
| 18 Jan 2023 | 100685495 | Hdfc Bank Limited | ₹14.45 Lakh | Open | |
| 08 Nov 2022 | 100679028 | Hdfc Bank Limited | ₹18 Lakh | Open | |
| 25 Jul 2022 | 100678821 | Hdfc Bank Limited | ₹50 Lakh | Open | |
| 31 Jan 2022 | 100547412 | Hdfc Bank Limited | ₹11 Lakh | Open |
Total charge records: 6 View all charges
Legal cases
Oziel Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Total cases
2
Filed against the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Sun Pharmaceutical Industries Ltd. | Disposed |
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed against the company by State Government | Disposed |
To see the full case history of Oziel Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oziel Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Oziel Pharmaceuticals Private Limited has a workforce of 66 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
Employee count
66
Active EPFO establishments
1
Employee growth
-2.94%
GST
Oziel Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCO1538J1ZC | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Oziel Pharmaceuticals Private Limited, buy the company report.
Recent activity
Oziel Pharmaceuticals Private Limited has 5 board changes on record since 2015: 5 appointments. The latest: Kamal Kishore Singh was appointed as Director on 03 Jun 2015.
AGM
Oziel Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Oziel Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 14.00 Lakh with Charge ID 100839162 was registered on 18 Dec 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 14.45 Lakh with Charge ID 100685495 was registered on 18 Jan 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 18.00 Lakh with Charge ID 100679028 was registered on 08 Nov 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 50.00 Lakh with Charge ID 100678821 was registered on 25 Jul 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 11.00 Lakh with Charge ID 100547412 was registered on 31 Jan 2022.
Charges
A charge with Others amounted to Rs. 22.20 Lakh with Charge ID 100339562 was registered on 04 Jun 2020.
Appointed
Kamal Kishore Singh was appointed as Director.
Appointed
Manish Mishra was appointed as Director.
Appointed
Mayank Chaubey was appointed as Director.
Appointed
Ritesh Kumar Gupta was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Oziel Pharmaceuticals is an active private limited company based in Noida, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 June 2015 (11+ years old) and is registered under CIN U85191UP2015PTC071100.
Oziel Pharmaceuticals has 5 current directors:
- Kamal Kishore Singh - Director
- Manish Mishra - Director
- Mayank Chaubey - Director
- Vamsi Vijjapu - Director
- Ritesh Kumar Gupta - Director
The latest financial statements of Oziel Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Oziel Pharmaceuticals is 09AACCO1538J1ZC, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Oziel Pharmaceuticals is U85191UP2015PTC071100. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oziel Pharmaceuticals has 2 court cases on record: 2 filed against it. Most are in the district courts.
Oziel Pharmaceuticals was incorporated on 03 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Oziel Pharmaceuticals by revenue are Banson Pharmaceuticals Private Limited, Sabkind Pharmaceuticals India Private Limited, Maharshi Badri Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kamal Kishore Singh was appointed as Director on 03 Jun 2015. Manish Mishra was appointed as Director on 03 Jun 2015. Mayank Chaubey was appointed as Director on 03 Jun 2015. Oziel Pharmaceuticals has 5 board changes on record in total.
Yes, Oziel Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-UP-28-0022153).
Oziel Pharmaceuticals can be reached through the website oziel.co.in. Its registered office is in Noida, Uttar Pradesh, India.